CP55,244
| Code | Size | Price |
|---|
| TAR-T27065-5mg | 5mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
CP55,244 is a CB(1) receptor and CB(2) receptor agonist.
CAS:
79732-51-7
Formula:
C26H42O3
Molecular Weight:
402.619
Purity:
0.98
SMILES:
[H][C@@]12CC[C@H](CO)C[C@@]1([H])[C@@H](C[C@H](O)C2)c1ccc(cc1O)C(C)(C)CCCCCC
References
1. Kinsey SG, Mahadevan A, Zhao B, Sun H, Naidu PS, Razdan RK, Selley DE, Imad Damaj M, Lichtman AH. The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects. Neuropharmacology. 2011 Feb-Mar;60(2-3):244-51. doi: 10.1016/j.neuropharm.2010.09.004. PubMed PMID: 20849866; PubMed Central PMCID: PMC3021987.
2. Tong W, Collantes ER, Welsh WJ, Berglund BA, Howlett AC. Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis. J Med Chem. 1998 Oct 22;41(22):4207-15. PubMed PMID: 9784095.
3. Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharmacol Exp Ther. 1988 Dec;247(3):1046-51. PubMed PMID: 2849657.